Our results are consistent with previous reports in other tumors that ENO1 functions as an oncogene [13,14,29,34] but are in contrast with Zhou et al.’s report that ENO1 overexpression suppressed EMT in NSCLC A549 cell line [16]. The gene discussed is ENO1; the disease is non-small cell lung carcinoma.